• Twitter
  • Jobs
ProCURE oncology
  • HOME
  • ABOUT US
  • RESEARCH GROUP
    • Molleví’s Lab
    • Antolin’s Lab
    • Alemany’s & Piulats’s lab
    • Martínez-Balibrea’s Lab
    • Aytes’s Lab
    • Belver’s Lab
    • Pujana’s Lab
    • Menendez’s Lab
    • Sureda’s & Farre’s Lab
    • Casanovas’s Lab
    • Viñals’s lab
  • INNOVATION
  • NEWS
  • CONTACT
  • Menu Menu

Silibinin is a natural molecular glue that inhibits PD-L1 glycomaturation

28 de June de 2026
Phytomedicine. 2026 Jun 25;159:158481. doi: 10.1016/j.phymed.2026.158481.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2026-06-28 10:00:002026-06-28 10:00:00Silibinin is a natural molecular glue that inhibits PD-L1 glycomaturation

Fatty acid synthesis therapy-induced senescence (FASTIS) in cancer cells

17 de June de 2026
Cell Death Dis. 2026 Jun 17. doi: 10.1038/s41419-026-08992-8.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2026-06-17 10:00:002026-06-17 10:00:00Fatty acid synthesis therapy-induced senescence (FASTIS) in cancer cells

Epigenetic Clocks in the Cosmic Silence of a Deep Underground Laboratory: Implications for Aging and Space Exploration

15 de June de 2026
Aging Dis. 2026 Jun 5. doi: 10.14336/AD.2026.0468. Online ahead…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2026-06-15 10:00:002026-06-15 10:00:00Epigenetic Clocks in the Cosmic Silence of a Deep Underground Laboratory: Implications for Aging and Space Exploration

Cellular Senescence in the Absence of Galactic Cosmic-Ray Muons

3 de June de 2026
Aging Dis. 2026 May 18. doi: 10.14336/AD.2026.0025. Online ahead…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2026-06-03 10:00:002026-06-03 10:00:00Cellular Senescence in the Absence of Galactic Cosmic-Ray Muons

Characterising Epigenetic Tipping Points using a Spectral Dimension Reduction Approach

18 de March de 2026
Bull Math Biol. 2026 Mar 18;88(4):57. doi: 10.1007/s11538-026-01602-w.ABSTRACTEpigenetic…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2026-03-18 10:00:002026-03-18 10:00:00Characterising Epigenetic Tipping Points using a Spectral Dimension Reduction Approach

Mitochondrial bioenergetics-SASP crosstalk determines senolytic efficacy in therapy-induced senescence

19 de February de 2026
Cell Death Discov. 2026 Feb 19. doi: 10.1038/s41420-026-02967-6.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2026-02-19 11:00:002026-02-19 11:00:00Mitochondrial bioenergetics-SASP crosstalk determines senolytic efficacy in therapy-induced senescence

Mitochondrial priming in therapy-induced senescence: implications for CAR-T/NK immunosenolytic therapy

24 de November de 2025
Front Immunol. 2025 Nov 7;16:1695244. doi: 10.3389/fimmu.2025.1695244.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2025-11-24 11:00:002025-11-24 11:00:00Mitochondrial priming in therapy-induced senescence: implications for CAR-T/NK immunosenolytic therapy

The STAT3/TIMP1 inhibitor silibinin overcomes secondary immunoresistance to pembrolizumab in brain metastases from METex14 skipping mutated non-small cell lung cancer: a case report

24 de July de 2025
Front Med (Lausanne). 2025 Jul 9;12:1612327. doi: 10.3389/fmed.2025.1612327.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2025-07-24 10:00:002025-07-24 10:00:00The STAT3/TIMP1 inhibitor silibinin overcomes secondary immunoresistance to pembrolizumab in brain metastases from METex14 skipping mutated non-small cell lung cancer: a case report

Metabolic hallmarks of trastuzumab resistance

11 de July de 2025
Expert Opin Ther Targets. 2025 Jul 11. doi: 10.1080/14728222.2025.2532394.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2025-07-11 10:00:002025-07-11 10:00:00Metabolic hallmarks of trastuzumab resistance

RETRACTED: Cejuela et al. Metformin and Breast Cancer: Where Are We Now? Int. J. Mol. Sci. 2022, 23, 2705

13 de June de 2025
Int J Mol Sci. 2025 Jun 5;26(11):5407. doi: 10.3390/ijms26115407.ABSTRACTThe…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2025-06-13 10:00:002025-06-13 10:00:00RETRACTED: Cejuela et al. Metformin and Breast Cancer: Where Are We Now? Int. J. Mol. Sci. 2022, 23, 2705

Direct Ink Writing of 3D-Structured All-Carbon Electrodes with High Electrical Conductivity for (Vanadium) Redox Flow Batteries

16 de May de 2025
Adv Sci (Weinh). 2025 May 15:e2417641. doi: 10.1002/advs.202417641.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2025-05-16 10:00:002025-05-16 10:00:00Direct Ink Writing of 3D-Structured All-Carbon Electrodes with High Electrical Conductivity for (Vanadium) Redox Flow Batteries

Lead exposure, peripheral neurotransmitter levels and cognitive control: A neurobehavioral study in children from Montevideo, Uruguay

6 de April de 2025
Neurotoxicology. 2025 Apr 4:S0161-813X(25)00035-X. doi: 10.1016/j.neuro.2025.03.009.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2025-04-06 10:00:002025-04-06 10:00:00Lead exposure, peripheral neurotransmitter levels and cognitive control: A neurobehavioral study in children from Montevideo, Uruguay
Page 1 of 11123›»

Filter by categories

  • Alemany’s & Piulats’s lab (131)
  • Antolin's lab (36)
  • Aytes's Lab (24)
  • Belver's Lab (25)
  • Casanovas's Lab (77)
  • Martínez-Balibrea's Lab (43)
  • Menendez's Lab (121)
  • Molleví's Lab (35)
  • Pujana's Lab (110)
  • Sureda's & Farre's Lab (259)
  • Viñals's lab (111)

Twitter

Tweets by ProcureICO
Program Against Cancer Therapeutic Resistance

CONTACT US

Campus IDIBELL
(L’Hospitalet del Llobregat)
Hospital Duran i Reynals, Gran Via 199,
L’Hospitalet del Llobregat,
Barcelona 08908
Tel. +34 93 260 7952

Campus IGTP-IJC
(Badalona)
Campus Can Ruti – IGTP – Building Muntanya,
Rd. Can Ruti, Camí de les escoles s/n,
Badalona, Barcelona 08916
Tel. +34 93 554 3069

Campus IDIBGI
(Girona)
Parc Hospitalari Martí i Julià de Salt, Dr. Castany s/n,
Salt, Girona 17190
Tel. +34 872 987 087

© Copyright - Edisenius
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
Scroll to top
Manage cookie consent
To offer the best experiences, we use technologies such as cookies to store and/or access device information. Consent to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent, or withdrawal of consent, may adversely affect certain features and functions.
Functional Always active
Storage or technical access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. Storage or technical access that is used exclusively for anonymous statistical purposes. Without a requirement, voluntary compliance by your Internet service provider, or additional records from a third party, information stored or retrieved solely for this purpose cannot be used to identify you.
Marketing
Storage or technical access is necessary to create user profiles to send advertising, or to track the user on a website or several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
See preferences
{title} {title} {title}